Centene (CNC) closed at $74.17 on November 5, 2026, down 2.4% from the previous close, on volume of 6,898,030 shares (30-day average 4,781,799).
Data as of November 5, 2026.
5-Nov-2026
Four undervalued healthcare stocks with the highest year-over-year CapEx growth
Seeking Alpha News (Thu, 5-Nov 8:00 AM ET)
Blue wave lifts hospital stocks, health insurers
Seeking Alpha News (Wed, 4-Nov 12:50 PM ET)
How health care is on the ballot in the midterms
Seeking Alpha News (Tue, 3-Nov 12:13 PM ET)
What the midterms mean for managed care
Seeking Alpha News (Tue, 3-Nov 12:05 PM ET)
Value vs. growth tops 10%, the most since 2000-2001
Seeking Alpha News (Mon, 2-Nov 12:19 PM ET)
CENTENE CORPORATION REPORTS THIRD QUARTER 2026 RESULTS
PRNewswire (Tue, 27-Oct 6:00 AM ET)
PRNewswire (Thu, 22-Oct 8:00 AM ET)
PRNewswire (Tue, 20-Oct 7:01 AM ET)
CENTENE CORPORATION TO HOST 2026 THIRD QUARTER FINANCIAL RESULTS EARNINGS CALL
PRNewswire (Mon, 19-Oct 5:31 PM ET)
PRNewswire (Fri, 16-Oct 8:00 AM ET)
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
Centene trades on the NYSE stock market under the symbol CNC.
As of November 5, 2026, CNC stock price declined to $74.17 with 6,898,030 million shares trading.
CNC has a beta of 1.19, meaning it tends to be more sensitive to market movements. CNC has a correlation of 0.09 to the broad based SPY ETF.
CNC has a market cap of $36.72 billion. This is considered a Large Cap stock.
Last quarter Centene reported $51 billion in Revenue and $.58 earnings per share. This beat revenue expectation by $4 billion and exceeded earnings estimates by $.49.
In the last 3 years, CNC traded as high as $81.42 and as low as $25.08.
The top ETF exchange traded funds that CNC belongs to (by Net Assets): VTI, VOO, IVV, SPY, VFLO.
CNC has outperformed the market in the last year with a price return of +105.4% while the SPY ETF gained +9.7%. CNC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +15.8% and +5.6%, respectively, while the SPY returned -4.7% and -5.2%, respectively.
CNC support price is $74.06 and resistance is $77.96 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNC shares will trade within this expected range on the day.